Menopoza kar\u015f\u0131 en etkili tedavi y\u00f6ntemi olan \u201cHormon Replasman\u201d\u0131n kalp-damar hastal\u0131klar\u0131ndan Alzheimer ve kansere kadar bir\u00e7ok hastal\u0131\u011fa kar\u015f\u0131 koruma sa\u011flad\u0131\u011f\u0131 saptand\u0131. Hormon Replasman ayr\u0131ca, postmenopozal d\u00f6nemdeki kad\u0131nlar\u0131n baz\u0131 hastal\u0131klara yakalanma riskini y\u00fczde 50 azalt\u0131yor.<\/p>\n
19. y\u00fczy\u0131l Victoria d\u00f6nemi fizik\u00e7ileri, \u201cmenopozun ciddilik derecesi\u201dni kad\u0131n\u0131n ge\u00e7mi\u015findeki d\u00fc\u015f\u00fcncesizlikleriyle orant\u0131 kurarak hesaplarm\u0131\u015f. 20. y\u00fczy\u0131l\u0131n ilk yar\u0131s\u0131nda psikanalistler, menopozun orta ya\u015ftaki kad\u0131n\u0131n hayat\u0131nda bir d\u00f6n\u00fcm noktas\u0131 oldu\u011funu d\u00fc\u015f\u00fcnd\u00fcler. \u015fimdiyse bilinen t\u00fcm ger\u00e7ekler de\u011fi\u015fti, menopozun san\u0131ld\u0131\u011f\u0131 gibi uzun, tek bir d\u00f6nemden de\u011fil, ya\u015fa ba\u011fl\u0131 olarak birbirini izleyen pre-peri-post olmak \u00fczere \u00fc\u00e7 evreden olu\u015ftu\u011fu ve buna uygun tedavi y\u00f6ntemleri izlenmesi gerekti\u011fi anla\u015f\u0131ld\u0131.Bu yeni bilgiler \u0131\u015f\u0131\u011f\u0131nda yap\u0131lan ara\u015ft\u0131rmalar, menopozla azalan \u00f6strojen ve progesteron Hormonlar\u0131n\u0131n g\u00f6evini yapan Hormon Replasman Tedavisi\u2019ne de farkl\u0131 bak\u0131\u015f a\u00e7\u0131lar\u0131 kazand\u0131rd\u0131. Bu tedavinin menopoz d\u00f6neminde kad\u0131nlardaki etkileri \u00fczerine yap\u0131lan ara\u015ft\u0131rmalar hem \u015fa\u015f\u0131rt\u0131c\u0131 sonu\u00e7lar sundu, hem de erken te\u015fhis ve tedavi ile iyile\u015fme oran\u0131n ne kadar y\u00fckseldi\u011fini g\u00f6sterdi.Hayati \u00f6nemi var!Ge\u00e7ti\u011fimiz 10 y\u0131l boyunca ara\u015ft\u0131rmac\u0131lar Hormon Replasman Tedavisi\u2019nin v\u00fccudu kalp krizinden Alzheimer hastal\u0131\u011f\u0131na kadar bir\u00e7ok hastal\u0131ktan korudu\u011funu ke\u015ffettiler. Hormon Replasman Tedavisi g\u00f6enler ile g\u00f6meyenler aras\u0131nda yap\u0131lan klinik deneyler, ortaya \u00f6nemli bir sonu\u00e7 \u00e7\u0131kard\u0131: G\u00f6\u011f\u00fcs Kanseri te\u015fhisi yap\u0131lan kad\u0131nlar aras\u0131nda Hormon Replasman Tedavisi olan kad\u0131nlar\u0131n hayatta kalabilme oran\u0131 di\u011ferlerine g\u00f6e daha y\u00fcksek!Postmenopoz d\u00f6neminde, kalp-damar hastal\u0131klar\u0131n\u0131n g\u00f6\u00fclme riskinin g\u00f6\u011f\u00fcs kanserinden 10 kat fazla oldu\u011fu ve Hormon Replasman Tedavisi\u2019nin bu riski y\u00fczde 50 oran\u0131nda azaltt\u0131\u011f\u0131, ke\u015ffedilen bir ba\u015fka ger\u00e7ek.Rahim Kanserini \u00f6nl\u00fcyorArch Intern Med\u2019in 1991\u2032de yay\u0131mlad\u0131\u011f\u0131 bir ba\u015fka ara\u015ft\u0131rman\u0131n iyi haberi ise Hormon Replasman Tedavisi ve erken te\u015fhis ile g\u00f6\u011f\u00fcs kanserinden \u00f6l\u00fcmlerde y\u00fczde 19 azalma sa\u011fland\u0131\u011f\u0131. Klinik ara\u015ft\u0131rmalar, rahim kanserinde de \u00f6nemli geli\u015fmeler haber veriyor. Menopoz ya da \u00f6ncesinde rahimde olu\u015fan t\u00fcm\u00f6, Kanser olmadan erken te\u015fhis ve tedavi sayesinde iyile\u015ftirilebiliyor, ya\u015fama oran\u0131 y\u00fczde 96.7\u2032ye \u00e7\u0131k\u0131yor. Ayr\u0131ca \u00f6strojen ile d\u00fc\u015f\u00fck dozda progestron i\u00e7eren Hormon Replasman Tedavisi, rahim kanseri riskine kar\u015f\u0131 koruma sa\u011fl\u0131yor. Ancak kansere kar\u015f\u0131 esas koruma, d\u00fczenli hekim kontrol\u00fc sayesinde erken te\u015fhisin yap\u0131labilmesi ve menopozun farkl\u0131 evrelerine uygun tedavinin s\u00fcrd\u00fcr\u00fclmesiyle m\u00fcmk\u00fcn oluyor.\u0130sve\u00e7\u2019te 23 bin kad\u0131n \u00fczerinde yap\u0131lan bir ara\u015ft\u0131rma ise \u00f6strojen ve progesteron i\u00e7eren Hormon Replasman Tedavisi\u2019nin kalp krizi riskini y\u00fczde 50 d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fcn\u00fc ortaya koyuyor.Menopoz hakk\u0131ndaki ger\u00e7ekler:Premenopoz: Premenopoz, menopoz \u00f6ncesi d\u00f6nemi temsil eder. Premenopoz, perimenopozu da kapsayan \u00e7ok geni\u015f bir d\u00f6nemi g\u00f6sterir ancak tipik menopoz s\u0131k\u0131nt\u0131lar\u0131, perimenopozla birlikte ba\u015flar.Perimenopoz: Perimenopoz, premenopozun i\u00e7inde ba\u015flay\u0131p son adet tarihinden bir y\u0131l sonras\u0131na kadar devam eder. Perimenopoz, d\u00fczensiz kanamalar, S\u0131cak basmas\u0131, terleme, huzursuzluk, bitkinlik gibi tipik menopoz \u015fikayetlerinin en yo\u011fun ya\u015fand\u0131\u011f\u0131 d\u00f6nemdir. Novo Norvodisk\u2019in perimenopozal d\u00f6nemi kolayla\u015ft\u0131rmak amac\u0131yla geli\u015ftirdi\u011fi Trisequens, bu d\u00f6nemdeki tipik menopoz \u015fikayetlerini ortadan kald\u0131r\u0131p, adetlerin d\u00fczenli olarak devam\u0131n\u0131 sa\u011flar.Postmenopoz: Perimenopozu takip eden ve son adet tarihinden bir y\u0131l sonra ba\u015flayan postmenopozal d\u00f6nemde, tipik menopoz \u015fikayetleri halen g\u00f6\u00fcl\u00fcr. Postmenopozal d\u00f6nem \u015fikayetleri kendi i\u00e7inde \u00fc\u00e7e ayr\u0131labilir. K\u0131sa vadeli semptomlar perimenopozal d\u00f6nemde yo\u011fun g\u00f6\u00fclen s\u0131cak basmas\u0131, s\u0131k\u0131nt\u0131 gibi \u015fik\u00c3\u00a2yetlerdir. Orta vadede, en s\u0131k idrar ka\u00e7\u0131rma, a\u011fr\u0131l\u0131 idrara \u00e7\u0131kma gibi \u00fcriner sistem bozukluklar\u0131, vajinal kuruluk, a\u011fr\u0131l\u0131 cinsel ili\u015fki, vajinada ka\u015f\u0131nt\u0131 ve ac\u0131 gibi \u015fikayetler ba\u015fg\u00f6sterir. Uzun vadede ise \u00f6strojen eksikli\u011finden kaynaklanan kemik kayb\u0131 (osteoporoz) ile kardiyovask\u00fcler hastal\u0131k riski artar. \u0130lk kez \u00f6strojen ve progesteron hormonlar\u0131n\u0131 kesintisiz olarak ayn\u0131 tablette bar\u0131nd\u0131ran Kligest, hem bu d\u00f6nemdeki \u015fikayetleri ortadan kald\u0131r\u0131yor, uzun vadede kar\u015f\u0131la\u015f\u0131labilecek hastal\u0131klara kar\u015f\u0131 koruma sa\u011fl\u0131yor, hem de posmenopozal d\u00f6nemde art\u0131k adet g\u00f6mek istemeyen kad\u0131nlar\u0131n isteklerine cevap veriyor.Cerrahi menopoz: Yumurtal\u0131klar\u0131n (ve rahmin) cerrahi m\u00fcdahele ile al\u0131nmas\u0131 ile olu\u015fan cerrahi menopozda tek ba\u015f\u0131na \u00f6strojen tedavisi uygulan\u0131r. Rahmi al\u0131nm\u0131\u015f (histerektomize) kad\u0131nlar i\u00e7in tek ba\u015f\u0131na \u00f6strojen kullan\u0131m\u0131 uygun bir tedavi rejimi olabilir. Ara\u015ft\u0131rmalara g\u00f6e, cerrahi menopoza girmi\u015f ve Hormon Replasman Tedavisi almam\u0131\u015f kad\u0131nlar\u0131n kardivask\u00fcler hastal\u0131klardan yak\u0131nmalar\u0131 ayn\u0131 ya\u015ftaki di\u011fer kad\u0131nlardan 2 kat daha fazlad\u0131r. Estrofem, tek ba\u015f\u0131na \u00f6strojen verilmesinin uygun oldu\u011fu bu d\u00f6nemdeki kad\u0131nlarda \u00f6strojen ihtiyac\u0131n\u0131 kar\u015f\u0131lar.<\/p>\n","protected":false},"excerpt":{"rendered":"
Menopoza kar\u015f\u0131 en etkili tedavi y\u00f6ntemi olan \u201cHormon Replasman\u201d\u0131n kalp-damar hastal\u0131klar\u0131ndan Alzheimer ve kansere kadar bir\u00e7ok hastal\u0131\u011fa kar\u015f\u0131 koruma sa\u011flad\u0131\u011f\u0131 saptand\u0131. Hormon Replasman ayr\u0131ca, postmenopozal d\u00f6nemdeki kad\u0131nlar\u0131n baz\u0131 hastal\u0131klara yakalanma riskini y\u00fczde 50 azalt\u0131yor. 19. y\u00fczy\u0131l Victoria d\u00f6nemi fizik\u00e7ileri, \u201cmenopozun ciddilik derecesi\u201dni kad\u0131n\u0131n ge\u00e7mi\u015findeki d\u00fc\u015f\u00fcncesizlikleriyle orant\u0131 kurarak hesaplarm\u0131\u015f. 20. y\u00fczy\u0131l\u0131n ilk yar\u0131s\u0131nda psikanalistler, menopozun orta ya\u015ftaki kad\u0131n\u0131n hayat\u0131nda bir d\u00f6n\u00fcm[Devam\u0131n\u0131 Oku…]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[22524],"tags":[29256,29259],"_links":{"self":[{"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/posts\/15397"}],"collection":[{"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/comments?post=15397"}],"version-history":[{"count":0,"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/posts\/15397\/revisions"}],"wp:attachment":[{"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/media?parent=15397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/categories?post=15397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gncz.net\/index.php\/wp-json\/wp\/v2\/tags?post=15397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}